Button to scroll to the top of the page.



From the College of Natural Sciences

Cheaper disease treatments expected from faster approach to developing therapeutic antibodies

AUSTIN, Texas--A method of mass-producing disease-fighting antibodies entirely within bacteria has been developed by a research group at The University of Texas at Austin. The group led by Dr. George Georgiou developed the new antibody-production approach to improve upon processes used previously to identify new drugs.  Drug companies have used th...

Texas Researchers Aim to Use Saliva To Diagnose Health and Disease

AUSTIN, Texas—Innovative saliva-based health diagnostic tools will be developed by researchers at The University of Texas at Austin through a $6 million, multi-institutional grant from the National Institutes of Health (NIH). Saliva—with its slimy mix of proteins, hormones and antibodies—can tell a lot about a person’s health, and it is much easie...

Biologist receives $450,000 grant to contribute to asthma research

AUSTIN, Texas—A developmental biologist at The University of Texas at Austin has received a $450,000 grant from the Sandler Program for Asthma Research given to innovative scientists willing to step away from their area of research and tackle the riddle of asthma. Dr. John Wallingford, developmental biologist who will be studying asthma using t...John Wallingford

Cancer Fighter: Professor's Personal Battle Leads to Development of New Cancer Drug

Jonathan Sessler wanted to ignore the pain. After all, his senior year at the University of California at Berkeley gave him plenty of things to take his mind off the persistent aching he felt under his arm. There were exams to study for, chemistry labs to finish and grad school applications to worry about. But Sessler’s older brother Dan, a first-...Jonathan Sessler, Rowland Petitt Centennial Professor of Chemistry, is a “molecular engineer” who designs new molecules that could have drug and medical diagnostic applications.

Cancer drug extends cognitive function in patients with brain metastases

AUSTIN, Texas—The drug Xcytrin®, based on a molecule developed by chemists at The University of Texas at Austin, shows significant promise in prolonging cognitive function in patients with non-small cell lung cancer that has metastasized to the brain. Dr. Jonathan Sessler This result, presented at the annual meeting of the American Society o...Jonathan Sessler

De Lozanne honored for teaching excellence

AUSTIN, Texas--Dr. Arturo De Lozanne, Associate Professor of Molecular Cell and Development Biology, has been selected to receive the 2006 Jean Holloway Award for Teaching Excellence.  De Lozanne will join former Holloway laureates at a dinner in his honor on May 8. The Holloway Award began in 1970, when Jean and Sterling Holloway endowed one of T...
Student scientists create living bacterial photographs

Student scientists create living bacterial photographs

AUSTIN, Texas—Using Petri dishes full of genetically engineered E. coli instead of photo paper, students at The University of Texas at Austin and UCSF successfully created the first-ever bacterial photographs. Their work is published in this week’s issue of Nature (Nov. 24, 2005), which is focused on the emerging field of synthetic biology. The s...